期刊文献+

七氟醚预处理对体外循环冠状动脉旁路移植术病人围术期心肌的保护作用 被引量:20

Cardioprotective effects of sevoflurane preconditioning in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass
原文传递
导出
摘要 目的探讨七氟醚预处理对体外循环(CPB)下冠状动脉旁路移植术(CABG)病人心肌的保护作用。方法择期CPB下CABG病人40例,ASAⅡ级或Ⅲ级,随机分为2组(n=20):七氟醚组(S组)或异丙酚组(P组)。麻醉维持:P组靶控输注异丙酚,血浆靶浓度2~3μg/L,静脉输注芬太尼2~3μg·kg^-1·h^-1;S组夹闭主动脉前,吸入0.5%~2%七氟醚,静脉输注芬太尼2~3μg·kg^-1·h^-1,夹闭主动脉后靶控输注异丙酚,血浆靶浓度2~3μg/L,静脉输注芬太尼2~3μg·kg^-1·h^-1。于切皮前即刻、CPB前即刻、CPB后即刻、回ICU后即刻、6、12h记录心率(HR)、平均动脉压(MAP)、肺动脉楔压(PCWP)、中心静脉压(CVP)、心脏指数(CI)、体循环血管阻力指数(SVRI)。于麻醉诱导前、回ICU后即刻、6、12、24h采集静脉血,测定血清心肌肌钙蛋白I(cTnI)浓度。记录术后不良事件的发生情况。结果2组各时点MAP、PCWP、CVP、HR和SVRI比较差异无统计学意义(P>0.05);与切皮前即刻和P组比较,S组回ICU后各时点CI升高(P<0.05)。与P组比较,S组回ICU后各时点cTnI浓度降低(P<0.05)。2组病人术后均无死亡;2组心肌梗塞、房颤和心肌缺血的发生率差异无统计学意义(P>0.05);S组cTnI浓度>2ng/ml的发生率低于P组(P<0.05)。结论七氟醚预处理对体外循环下冠状动脉旁路移植术病人围术期心肌具有一定的保护作用。 Objective To investigate the protective effect of sevoflurane preconditioning on myocardium in patients undergoing coronary artery bypass grafting( CABG) under cardiopulmonary bypass( CPB). Methods Forty ASA Ⅱ or Ⅲ patients scheduled for CABG under CPB were randomized to 2 groups ( n = 20 ) : sevoflurane group (group S) and propofol group (group P). Anesthesia was maintained with propofol by target-controlled infusion (TCI) (plasma concentration 2-3 μg/L) and fentanyl infusion 2-3 μg·kg^-1·h^-1 in group P, and with inhalation of 0.5 %-2 % sevoflurane and fentanyl infusion 2-3 μg·kg^-1·h^-1 before aortic cross clamping, and TCI by propofol (plasma concentration 2-3μg/L) and fentanyl 2-3 μg·kg^-1 ·h^-1 after aortic cross clamping in group S. Heart rate (HR), mean arterial pressure (MAP), pulmonary capillary wedge pressure (PCWP), central venous pressure (CVP), cardiac index (CI), and systemic vascular resistance index (SVRI) were recorded before the start of surgery (baseline), before the start of CPB, after the end of CPB, at arrival in the intensive care unit(ICU) (T0), and 6 (T6 ) and 12 (T12) hours after arrival in ICU. Blood samples were taken before the induction of anesthesia, T0, T6 , T12 , and 24 hours after arrival in ICU ( T24 ) for determination of serum concentration of cardiac troponin I (cTnI). Postoperative cardiac events were recorded. Results The two groups were comparable with respect to MAP, PCWP, CVP, HR, and SVRI ( P 〉 0.05) ; CI was significantly increased postoperatively in group S compared with in group P and its baseline( P 〈 0.05) . Serum cTnI concentrations were significantly lower postoperatively in group S than in group P ( P 〈 0. 05) myocardial infarction, atrial fibrillation, and myocardial There was no significant difference in the incidences of ischemia between the two groups ( P 〉 0.05), but the incidence of serum cTnI concentration 〉 2 ng/ml was much less in group S than in group P(P 〈 0.05). Conclusion Sevoflttrane preconditioning exerts a certain eardioprotective effect in patients undergoing CABG under CPB.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2007年第6期508-511,共4页 Chinese Journal of Anesthesiology
关键词 缺血预处理 二异丙酚 心肺转流术 冠状动脉分流术 七氟醚 Ischemic preconditioning Propofol Cardiopulmonary bypass Coronary artery bypass Sevoflurane
  • 相关文献

参考文献12

  • 1Yu CH, Beattie WS. The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis. Can J Anaesth, 2006, 53: 906-918.
  • 2De Hert SG, Cromheecke S, ten Broecke PW, et al. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology, 2003, 99: 314-323.
  • 3De Hert SG, ten Broecke PW, Mertens E, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients.Anesthesiology, 2002, 97: 42-49.
  • 4De Hert SG, Van der Linden PJ, Cromheecke S, et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology, 2004, 101 : 9-20.
  • 5De Hert SG, Van der Linden PJ, Cromheecke S, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Auestheslology,2004,101 : 299-310.
  • 6El Azab SR, Scheffer GJ, Rosseel PM, et al. Induction and maintenance of anaesthesia with sevoflurane in comparison to high dose opioid during coronary artery bypass surgery. Eur J Anaesthesiol, 2000, 17: 336-338.
  • 7Conzen PF, Fischer S, Detter C, et al. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology, 2003, 99: 826-833.
  • 8Garela C, Juller K, Bestmann L, et al. Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. Br J Anaesth, 2005, 94: 159-165.
  • 9Nader ND, Li CM, Khadra WZ, et al. Anesthetic myocardial protection with sevoflurane. J Cardiothorac Vasc Anesth, 2004, 18 : 269-274.
  • 10Julier K, da Silva R, Garcia C, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebocontrolled, multicenter study. Anesthesiology, 2003, 98 : 1315-1327.

同被引文献197

引证文献20

二级引证文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部